Recent findings (Zhang et al., 2021b) indicated that Ar could confer protection against LPS-induced AKI by inhibiting inflammation and apoptosis through the Akt signaling pathway, thereby establishing a molecular foundation for innovative therapeutic strategies for AKI. The gene discussed is AKT1; the disease is acute kidney injury.